Unraveling Reaven’s Syndrome X: Serum Insulin-Like Growth Factor-I and Cardiovascular Disease
- 27 May 2003
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (20), e190
- https://doi.org/10.1161/01.cir.0000074245.18499.68
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cardiovascular Disease and Insulin-Like Growth Factor ICirculation, 2002
- Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart DiseaseCirculation, 2002
- Elevated Remnant-Like Particles in Heterozygous Familial Hypercholesterolemia and Response to Statin TherapyCirculation, 2002
- Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyThe Lancet, 2002
- Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitusAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarctionJournal of the American College of Cardiology, 2001
- A Polymorphism in the Gene for IGF-IDiabetes, 2001
- Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adultsClinical Endocrinology, 1999
- Serum Levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 in Healthy Centenarians: Relationship with Plasma Leptin and Lipid Concentrations, Insulin Action, and Cognitive FunctionJournal of Clinical Endocrinology & Metabolism, 1997
- Biochemical Correlates of Aortic Distensibility in vivo in Normal SubjectsClinical Science, 1993